Ledger.Open graph →
SEC Form D · filed November 30, 2016

PROCLARA BIOSCIENCES, INC

Offering
$47.0M
Sold
$43.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Daniel Lynch · Cambridge, MADirectorFranz Hefti, Ph.D · Cambrdige, MAExec · DirectorHans Schoepflin · Cambridge, MADirectorNick Leschly · Cambridge, MADirectorHampus Hillerstrom · Cambridge, MAExecRichard Fischer, Ph.D · Cambridge, MAExecPaul Goldenheim, Md · Cambridge, MADirectorPeter Smedvig · Cambridge, MADirectorJohn Dee · Cambridge, MADirectorHans Schoepflin · Cambridge, MADirectorNick Leschly · Cambridge, MADirectorHampus Hillerstrom · Cambridge, MAExecRichard Fischer, Ph.D · Cambridge, MAExecPaul Goldenheim, Md · Cambridge, MADirectorPeter Smedvig · Cambridge, MADirectorJohn Dee · Cambridge, MADirectorDaniel Lynch · Waltham, MADirectorFranz Hefti, Ph.D · Cambrdige, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗